Incentive Programs for Female Substance Abusers Who Smoke - 3
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by National Institute on Drug Abuse (NIDA).
Recruitment status was Active, not recruiting
Information provided by:
National Institute on Drug Abuse (NIDA)
First received: July 15, 2003
Last updated: May 23, 2008
Last verified: May 2008
The purpose of this study is to examine the effects of incentive programs for the treatment of nicotine dependence in women who have problems with substance dependence.
Tobacco Use Disorder
Behavioral: Behavior Therapy
||Primary Purpose: Treatment
||Incentive Programs for Female Substance Abusers Who Smoke
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
This study will determine the influence of voucher-based CM on reducing smoking (and other drug) use during pregnancy or in post-partum women with children under 1 year of age living with them, or in non-pregnant females who smoke. We are targeting smoking cessation since cigarette use is so prevalent in our service. We will compare a control group to two different voucher-based contingent-reinforcement procedures: one that targets smoking abstinence alone vs. one that offers additional incentives for negative BAL and urinalysis results.
|Ages Eligible for Study:
||15 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
- Pregnant and or post-partum with at least one child under 1 year old living with them, or non-pregnant, non-post-partum females or previous participant in this study protocol
- Nicotine Dependent as confirmed by DSM-IV checklist
- Current cigarette smoker
- Breath CO reading of at least 8 ppm at the time of the initial study screening
- Current client with the Shields for Families (Shields) treatment programs
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00064922
|Shields for Families, Inc.
|Los Angeles, California, United States, 90061 |
||Leslie Amass, Ph.D.
||Los Angeles Treatment Research Center
No publications provided
History of Changes
|Other Study ID Numbers:
|Study First Received:
||July 15, 2003
||May 23, 2008
||United States: Federal Government
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on May 21, 2015
Tobacco Use Disorder